Dual targeting of mTORC1 and mTORC2 by INK-128 potently inhibits human prostate cancer cell growth in vitro and in vivo.
about
Recent advances in targeting mTOR signaling pathway using small molecule inhibitors.Investigational serine/threonine kinase inhibitors against prostate cancer metastases.Preclinical study of CC223 as a potential anti-ovarian cancer agent.Mycophenolate Mofetil induces c-Jun-N-terminal kinase expression in 22Rv1 cells: an impact on androgen receptor signaling.
P2860
Dual targeting of mTORC1 and mTORC2 by INK-128 potently inhibits human prostate cancer cell growth in vitro and in vivo.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Dual targeting of mTORC1 and m ...... l growth in vitro and in vivo.
@en
Dual targeting of mTORC1 and m ...... l growth in vitro and in vivo.
@nl
type
label
Dual targeting of mTORC1 and m ...... l growth in vitro and in vivo.
@en
Dual targeting of mTORC1 and m ...... l growth in vitro and in vivo.
@nl
prefLabel
Dual targeting of mTORC1 and m ...... l growth in vitro and in vivo.
@en
Dual targeting of mTORC1 and m ...... l growth in vitro and in vivo.
@nl
P2860
P1433
P1476
Dual targeting of mTORC1 and m ...... l growth in vitro and in vivo.
@en
P2093
Shang-Jun Jiang
P2860
P2888
P304
P356
10.1007/S13277-015-3536-6
P577
2015-05-21T00:00:00Z